tirzepatide being discontinued Results — Weight Loss Timeline & What to Expect Zepbound copycats remain online despite

Patients in the 1.0 mg weekly dose arm lost an average of 10.5% body weight, while those on 2.4 mg lost 14.9%regardless of baseline fitness levels

For the LEAD-2 Study Group Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: The LEAD (liraglutide effect and action in diabetes)-2 study

Which is why we go so much deeper on this inside the endometriosis reset because medications are never the whole story, and we have to recognize that GLP ones for endometriosis aren't likely going to be covered by insurance and that they're pricey

Do not flush unused medications or pour down a sink or drain Best, C